Real-time enrollment status for this chronic myelogenous leukemia clinical trial
Current Status
Recruiting
Checked: August 31, 2026 at 7:36 AM UTC
| NCT Number | NCT07354074 |
| Recruiting Status | Recruiting |
| Condition | Chronic Myelogenous Leukemia |
| Phase | PHASE2 |
| Target Enrollment | 50 participants |
| Active Locations | 4 sites in the US |
| Sponsor | Novartis Pharmaceuticals |
| Last Updated on CT.gov | August 20, 2026 (1 week ago) |
As of August 31, 2026: Clinical trial NCT07354074 is currently recruiting participants. This phase2 study for chronic myelogenous leukemia is actively seeking new participants at 4 locations across the United States. The study is sponsored by Novartis Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07354074 is actively recruiting participants as of August 31, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 4 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07354074 was last updated 1 week ago (August 20, 2026). HelloStudys verifies this status automatically.